Analysts at StockNews.com initiated coverage on shares of Marchex (NASDAQ:MCHX - Get Free Report) in a report issued on Saturday. The brokerage set a "hold" rating on the technology company's stock.
Marchex Price Performance
NASDAQ:MCHX traded down $0.08 during mid-day trading on Friday, reaching $1.76. The stock had a trading volume of 16,975 shares, compared to its average volume of 20,867. The firm has a 50 day moving average price of $1.82 and a two-hundred day moving average price of $1.63. Marchex has a one year low of $1.11 and a one year high of $2.16. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.37.
Marchex (NASDAQ:MCHX - Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The technology company reported ($0.02) earnings per share for the quarter, meeting the consensus estimate of ($0.02). Marchex had a negative return on equity of 10.69% and a negative net margin of 8.60%. The firm had revenue of $12.07 million during the quarter, compared to the consensus estimate of $12.14 million. During the same quarter in the previous year, the company posted ($0.05) earnings per share. On average, sell-side analysts forecast that Marchex will post -0.08 EPS for the current fiscal year.
Institutional Trading of Marchex
A hedge fund recently raised its stake in Marchex stock. P.A.W. Capital Corp lifted its holdings in shares of Marchex, Inc. (NASDAQ:MCHX - Free Report) by 14.6% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 400,000 shares of the technology company's stock after acquiring an additional 51,000 shares during the quarter. Marchex makes up 1.5% of P.A.W. Capital Corp's portfolio, making the stock its 13th biggest position. P.A.W. Capital Corp owned 0.92% of Marchex worth $616,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 73.46% of the company's stock.
About Marchex
(
Get Free Report)
Marchex, Inc, a conversation intelligence company, provides conversational analytics and related solutions in the United States, Canada, and internationally. Its products include Marketing Edge that identifies which campaigns and channels are driving inbound conversations, evaluates what happens during those conversations, and closes the sales loop by connecting converted sales to marketing driven leads; Sonar Business Text Messaging, an artificial intelligence (AI) empowered intelligent workflow enabled mobile messaging solution that enables operations, sales, and marketing teams to communicate personally with field staff, prospects, and customers; Marchex Platform Services, a robust API-based conversation intelligence product that allows executives, sales, customer engagement, and marketing teams to apply Marchex AI to most any calls, regardless of communication platform, in order to identify actionable insights from conversations with their customers; Spotlight, an AI conversation analytics product for multi-location businesses; and Engage, a solution that provides locations with applications to enhance their overall performance.
Read More
Before you consider Marchex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.
While Marchex currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.